With over 40 years of experience, the toxicity testing capabilities of CiToxLAB comprise a vast array of designs, ranging from acute single dose studies to carcinogenicity studies, including specialty dose routes such as inhalation and infusion. All studies are fully GLP compliant in accordance with current guidelines or custom-designed for particular needs.
CiToxLAB’s four facilities are located in Europe (France, Denmark and Hungary) and North America (Canada). We offer close to 60,000 m2 of vivarium and supporting laboratories for the conduct of general and specific toxicology studies on: pharmaceuticals, biotechnology products and medical devices. Our clients include an impressive list of major pharmaceutical and biotech companies.